SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1961-01-01

Employees: -

Market Cap: -

Website: http://www.sbmu.ac.ir/

Clinical Trials

Fasudil Eye Drop in Retinopathy Of Prematurity(ROP)

Phase 2

Conditions: Retinopathy of Prematurity

Interventions: Drug: Fasudil eye drops (concentration 0.5 percent)
Drug: receive artificial tears drop

First Posted Date: 2019-12-10

Last Posted Date: 2019-12-10

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 184

Registration Number: NCT04191954

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Immunosuppression After Repeat Keratoplasty

Phase 2

Conditions: Keratopathy

Interventions: Drug: prescribe mycophenolate mofetil(MMF)
Drug: prescribe topical 0.03 % tacrolimus

First Posted Date: 2019-11-01

Last Posted Date: 2019-11-01

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 58

Registration Number: NCT04147390

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Establishment of the National Registry for Inherited Retinal Dystrophy in Iran

Conditions: Inherited Retinal Dystrophy Primarily Involving Sensory Retina
Inherited Retinal Dystrophy Primarily Involving Retinal Pigment Epithelium

Interventions: Diagnostic Test: Visual Acuity Testing and Retinal Imaging

First Posted Date: 2019-10-18

Last Posted Date: 2019-10-18

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 1000

Registration Number: NCT04131400

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Effects of Corneal Anatomical Match Between Donor and Recipient During DALK Surgery on Final Visual and Refractive Outcomes in Patients With KCN

Phase 2

Conditions: Keratoconus

Interventions: Procedure: After mechanical trephination, horizontal meridian of donor's cornea sutured to horizontal meridian of recipient cornea

First Posted Date: 2019-10-17

Last Posted Date: 2019-10-17

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 52

Registration Number: NCT04130334

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Short-term Additive Effect of Topical Ketorolac on the Management of Diabetic Macular Edema With Intravitreal Bevacizumab

Phase 2

Completed

Conditions: DME

Interventions: Drug: prescription topical ketorolac in group 1
Drug: prescription artificial tear in group 2
Drug: prescription topical ketorolac in group 2
Drug: prescription artificial tear in group1

First Posted Date: 2019-10-09

Last Posted Date: 2021-02-23

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 26

Registration Number: NCT04119921

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Relationship Between Cardiopulmonary Exercise Testing and Ca-P in Chronic Kidney Disease (CKD)

Completed

Conditions: Ckd-Mbd

Interventions: Diagnostic Test: CPET

First Posted Date: 2019-07-09

Last Posted Date: 2022-01-28

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 200

Registration Number: NCT04013139

Locations: 🇮🇷
Nooshin Dalili, Tehran, Iran, Islamic Republic of

Comparison Between Patching and Interactive Binocular Treatment (IBiTTM) in Amblyopia

Not Applicable

Conditions: The New Treatment in Amblyopia Therapy

Interventions: Device: Interactive Binocular Treatment
Procedure: Patching Therapy

First Posted Date: 2019-05-07

Last Posted Date: 2019-05-07

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 38

Registration Number: NCT03940222

Locations: 🇮🇷
Hamideh Sabbaghi, Tehran, Iran, Islamic Republic of

mHealth Intervention for Improving Eye Health at Community Level

Phase 3

Completed

Conditions: Visual Impairment

Interventions: Diagnostic Test: Screening program including 2 consecutive tests
Diagnostic Test: Screening program with mobile health

First Posted Date: 2019-04-19

Last Posted Date: 2019-04-23

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 3300

Registration Number: NCT03922347

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Pupil Centroid Shift Compensation in Photorefractive Keratectomy Candidates

Phase 2

Conditions: Pupil Centroid Shift

Interventions: Procedure: The option for compensation of Pupil centroid shift was ON
Procedure: The option for compensation of Pupil centroid shift was OFF
Drug: installation of Tetracaine 1%
Procedure: Photorefractive keratectomy (PRK)

First Posted Date: 2019-02-18

Last Posted Date: 2019-02-18

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 104

Registration Number: NCT03844178

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema

Phase 2

Conditions: Refractory Diabetic Macular Edema

Interventions: Drug: injection of bevacizumab and erythropoietin
Drug: injection of bevacizumab

First Posted Date: 2019-01-29

Last Posted Date: 2019-02-05

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 58

Registration Number: NCT03821168

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy